ProCE Banner Activity

Advances in Hemophilia A Treatment: A Peek Ahead to ASH 2019

Clinical Thought
Here’s my take on some of the most exciting hemophilia A studies being presented at the upcoming ASH 2019 meeting in Orlando.

Released: December 03, 2019

Expiration: December 01, 2020

Share

Faculty

Cindy A. Leissinger

Cindy A. Leissinger, MD

Director
Louisiana Center for Bleeding and Clotting Disorders
New Orleans, Louisiana

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Genentech TEXT Only

Faculty Disclosure

Primary Author

Cindy A. Leissinger, MD

Director
Louisiana Center for Bleeding and Clotting Disorders
New Orleans, Louisiana

Cindy Leissinger, MD, has disclosed that she has received funds for research support from Biogen, BioMarin, and Genentech/Roche and has served as a member of advisory committees for Bayer, CSL Behring, Genentech/Roche, HEMA Biologics, Kedrion, NovoNordisk, Pfizer, Spark, Takeda, and uniCure.